|
|
Archived Press Releases 2007
|
|
Dec 27, 2007
|
AspenBio Outlines Steps for FDA 510(k) Clearance of AppyScore™, the First Blood-based Screen/Triage Test for Human Appendicitis |
|
Dec 24, 2007
|
AspenBio Pharma Closes $18.2 Million Private Placement of Common Stock |
|
Dec 20, 2007
|
AspenBio Pharma Announces $18 Million Private Placement of Common Stock |
|
Oct 05, 2007
|
AspenBio Pharma to Present at the Oppenheimer Best Ideas 1x1 Conference |
|
Oct 04, 2007
|
AspenBio Pharma to Present at the Edgewater Research Investor Conference |
|
Sep 28, 2007
|
AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study |
|
Aug 29, 2007
|
AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference |
|
Aug 28, 2007
|
AspenBio Pharma Shares Commence Trading on the NASDAQ Capital Markets Exchange Under Symbol 'APPY' |
|
Aug 24, 2007
|
AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference |
|
Aug 21, 2007
|
AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol 'APPY' |
|
Aug 20, 2007
|
AspenBio Pharma Reports Second Quarter 2007 Results |
|
Aug 13, 2007
|
AspenBio Pharma to Present at the August Noble Financial Conference |
|
Jul 27, 2007
|
AspenBio Pharma Advances BoviPure FSH™ Reproduction Drug with FDA Filing and GMP Manufacturing Contract |
|
May 17, 2007
|
AspenBio Pharma Reports First Quarter 2007 Results |
|
May 16, 2007
|
AspenBio Pharma to Present at the Wall Street Analyst Forum's 18th Annual Institutional Investor Conference in New York City on May 22, 2007 |
|
May 08, 2007
|
AspenBio Pharma to Present at the 2007 Robins Emerging Opportunities Investment Conference in New York City on May 24, 2007 |
|
May 08, 2007
|
AspenBio Pharma Completes $9.3 Million Warrant Conversion |
|
Apr 06, 2007
|
AspenBio Pharma Corporate Profile |
|
Apr 02, 2007
|
AspenBio Pharma to Present at the Big Dog II Small Cap Conference |
|
Feb 22, 2007
|
AspenBio Pharma's New Human Appendicitis Blood Test Continues to Show High Accuracy in Clinical Trials |
|
Feb 01, 2007
|
AspenBio Pharma to Present at the Roth Capital Partners 19th Annual Conference |
|
Jan 16, 2007
|
AspenBio Pharma's Human Appendicitis Blood Test Shows Strong Preliminary Results as Clinical Diagnostic Aid |
|
Jan 04, 2007
|
AspenBio Pharma Investors Pay $2,078,000 in Cash Upon Exercise of Warrants |
|
Jan 03, 2007
|
AspenBio Pharma Files for FDA approval of BoviPure LH™ |
|
|
